⏳ Final hours! Save up to 60% OFF InvestingProCLAIM SALE

CVS Gains on Higher Dividend, $10-Billion Share Buyback

Published 2021-12-09, 08:04 a/m
© Reuters.

By Dhirendra Tripathi

Investing.com – CVS Health stock (NYSE:CVS) traded 2.4% higher in Thursday’s premarket as the company promised to return more money to shareholders through higher dividends and a $10 billion buyback.

The pharmacy chain also said it will meet the top end -- $290.3 billion -- of its current-year revenue estimates at the very least. Similarly, it expects to hit the high end of the adjusted EPS guidance too ($8) for the year while it held out hope of exceeding it.

The company is holding its 2021 Investor Day today and issued a statement ahead of it. CVS’s optimistic outlook comes amid a record period for the chain and its rivals including Walgreens (NASDAQ:WBA), all of whom have benefited from the Covid-19 fallout and concerns around health arising out of the pandemic.

The company also initiated guidance for the next year, projecting revenue of around $309 billion. 

It guided for adjusted earnings per share of $8.20 at midpoint of the range for the next financial year.

As part of its long-term growth trajectory, CVS is targeting a return to low double-digit adjusted EPS growth in 2024.

The company said it will increase its yearly dividend by 10% to $2.20, effective with the next dividend distribution on February 1.

Last month, the company said it will shut 900 stores over three years under its plan to shift to digital.

The company plans to turn some of its pharmacies into units that offer a range of medical services, from administering shots to conducting tests.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.